Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Fiona Hegi-Johnson"'
Autor:
Ross Andrew Soo, Mark Doherty, Arjun Sahgal, Ai Peng Tan, Mei Chin Lim, Benjamin J Solomon, Kristy P Robledo, Yu Yang Soon, Chee Khoon Lee, Mark B Pinkham, Fiona Hegi-Johnson, Shilo Lefresne, Cheryl Ho, Adrian G Sacher, Alan Nichol, Ambika Parmar, David B Shultz, Ivan WK Tham, Jeremy Tey, Cheng Nang Leong, Wee Yao Koh, Yiqing Huang, Yvonne Li En Ang, Jiali Low, Clement Yong
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Background Patients with advanced non-small-cell lung cancer (NSCLC) with activating mutations in the epidermal growth factor receptor (EGFR) gene are a heterogeneous population who often develop brain metastases (BM). The optimal management of patie
Externí odkaz:
https://doaj.org/article/d2149842a0cd4925972e09dd5e72943d
Autor:
Camille E Short, Jonathan C Rawstorn, Tamara L Jones, Lara Edbrooke, Sandra C Hayes, Ralph Maddison, Sophie Nightingale, Hilmy Ismail, Richard De Boer, Fiona Hegi-Johnson, Aaron L Sverdlov, Robyn Bell, Irene Halligan, Linda Denehy
Publikováno v:
JMIR Research Protocols, Vol 13, p e53301 (2024)
BackgroundExercise rehabilitation is a promising strategy for reducing cardiovascular disease risk among patients with breast cancer. However, the evidence is primarily derived from programs based at exercise centers with in-person supervised deliver
Externí odkaz:
https://doaj.org/article/621dc114db5f4d5fae83ce4b8c3026bf
Autor:
Michael MacManus, Laura Kirby, Benjamin Blyth, Owen Banks, Olga A. Martin, Miriam M. Yeung, Nikki Plumridge, Mark Shaw, Fiona Hegi-Johnson, Shankar Siva, David Ball, Stephen Q. Wong
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 43, Iss , Pp 100682- (2023)
Background: The kinetics of circulating tumor DNA (ctDNA) release following commencement of radiotherapy or chemoradiotherapy may reflect early tumour cell killing. We hypothesised that an increase in ctDNA may be observed after the first fraction of
Externí odkaz:
https://doaj.org/article/c015ce5334774a8781e42cb427f8ac08
Autor:
Fiona Hegi-Johnson, Stacey Rudd, Rodney J. Hicks, Dirk De Ruysscher, Joseph A. Trapani, Thomas John, Paul Donnelly, Benjamin Blyth, Gerard Hanna, Sarah Everitt, Peter Roselt, Michael P. MacManus
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-15 (2022)
Abstract Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged survival, for a subset of cancer patients with an otherwise dire prognosis. However, it remains unclear why some patients respond to immunot
Externí odkaz:
https://doaj.org/article/5d38189bd1004ec4a08c3e6cbbdf9ecf
Autor:
Fiona Hegi-Johnson, Kristin A. Higgins
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/0dbc7ac09f7b4d53b14c49686ba77af8
Autor:
Christian Wichmann, Sagun Parakh, Gerard G Hanna, Thomas John, Jason Callahan, Benjamin Blyth, Michael MacManus, Daniel Steinfort, Andrew M Scott, Lisa Devereux, Fiona Hegi-Johnson, Stacey E Rudd, Tim Akhurst, Peter Roselt, Jenny Trinh, Paul S Donnelly, Rod Hicks, Stephen Fox, Kate Burbury
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Background ImmunoPET is a multicentre, single arm, phase 0–1 study that aims to establish if 89Zr-durvalumab PET/CT can be used to interrogate the expression of PD-L1 in larger, multicentre clinical trials.Methods The phase 0 study recruited 5 PD-L
Externí odkaz:
https://doaj.org/article/3ec7e11a980b4b738c6b1a546c955538
Autor:
Sarah Hegarty, Nicholas Hardcastle, James Korte, Tomas Kron, Sarah Everitt, Sulman Rahim, Fiona Hegi-Johnson, Rick Franich
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Delivering radiotherapy to patients in an upright position can allow for increased patient comfort, reduction in normal tissue irradiation, or reduction of machine size and complexity. This paper gives an overview of the requirements for the delivery
Externí odkaz:
https://doaj.org/article/f23c4d5a3ea947b6a9ed529c7c6901c6
Autor:
Fiona, Hegi-Johnson, Stacey E, Rudd, Christian, Wichmann, Tim, Akhurst, Peter, Roselt, Jenny, Trinh, Thomas, John, Lisa, Devereux, Paul S, Donnelly, Rod, Hicks, Andrew M, Scott, Daniel, Steinfort, Stephen, Fox, Benjamin, Blyth, Sagun, Parakh, Gerard G, Hanna, Jason, Callahan, Kate, Burbury, Michael, MacManus
Publikováno v:
BMJ open. 12(11)
ImmunoPET is a multicentre, single arm, phase 0-1 study that aims to establish ifThe phase 0 study recruited 5 PD-L1+ patients with metastatic non-small cell lung cancer (NSCLC). Patients received 60MBq/70 kgThis phase 0 study has ethics approval (HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f68c797be37a4a0236cd2c911a5320e2
https://pubmed.ncbi.nlm.nih.gov/36400733
https://pubmed.ncbi.nlm.nih.gov/36400733
Autor:
Michael MacManus, Fiona Hegi-Johnson
Publikováno v:
The Lancet Oncology. 23:191-193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab416fcdcd7c40fec7d49df334da28d1
https://doi.org/10.1016/s1470-2045(21)00711-7
https://doi.org/10.1016/s1470-2045(21)00711-7
Autor:
Christian W. Wichmann, Stan Poniger, Nancy Guo, Peter Roselt, Stacey E. Rudd, Paul S. Donnelly, Benjamin Blyth, Jessica Van Zuylekom, Angela Rigopoulos, Ingrid J.G. Burvenich, Laurence Morandeau, Shifaza Mohamed, Anna K. Nowak, Fiona Hegi-Johnson, Michael MacManus, Andrew M. Scott
Publikováno v:
Nuclear Medicine and Biology. :108351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17b1d30333a59f08b6a7ecd831e3f1d5
https://doi.org/10.1016/j.nucmedbio.2023.108351
https://doi.org/10.1016/j.nucmedbio.2023.108351